Skip to main content
Clinical Trials/DRKS00004159
DRKS00004159
Completed
N/A

Investigation and validation of the diagnostic performance of new biomarker candidates for (I) the early detection of an infectious origin of neutropenic fever and for the prediction of (II) an infection of patients after apoplectic stroke and the progression of (III) a nosocomial infection or (IV) a community acquired pneunomia to a severe sepsis/ septic shock - Lab-ALERTS

Institut für Klinische Chemie und Laboratoriumsdiagnostik / Integriertes Forschungs- und Behandlungszentrum Sepsis und Sepsisfolgen0 sites1,018 target enrollmentJuly 17, 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
A41.9
Sponsor
Institut für Klinische Chemie und Laboratoriumsdiagnostik / Integriertes Forschungs- und Behandlungszentrum Sepsis und Sepsisfolgen
Enrollment
1018
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 17, 2012
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Institut für Klinische Chemie und Laboratoriumsdiagnostik / Integriertes Forschungs- und Behandlungszentrum Sepsis und Sepsisfolgen

Eligibility Criteria

Inclusion Criteria

  • I) patients with hemato\-malignancies who are expected to develop neutropenia during/ after chemotherapy, age \= 18 (297 patients, recruitment in this study);
  • II) Ischemic stroke in the territory of A. cerebri media (or beyond), age \= 18, NIH stroke score (NIHSS) \> 8 (136 patients, recruitment in PRED\-SEP study, DRKS00003392\);
  • III) hospital stay of \>48 hours and nosocomial infection (4219 patients, recruitment in this study);
  • IV) patienten with community acquired pneumonia (400 patients, recruitment in PROGRESS\-CAP study)

Exclusion Criteria

  • II) infection present upon hospital atmittance; anamnesis of a previous stroke; cardiac arrhythmia;

Outcomes

Primary Outcomes

Not specified

Similar Trials